Women who are pregnant or planning to become pregnant should avoid using semaglutide and consult their healthcare provider for alternative options
These products are not intended for human consumption, veterinary use, self-administration, clinical use, treatment, diagnosis, prevention, cosmetic use, supplement use, body composition use or any form of personal use
The review highlights data from randomized controlled trials and meta-analyses that demonstrate reductions in both apnea-hypopnea index (AHI) and body weight among patients treated with GLP-1RA and dual GLP-1 and glucose-dependent insulinotropic peptide (GIP) receptor agonists
Obesity and weight management for the prevention and treatment of diabetes: standards of Care in Diabetes-2026
Important safety information Compounded medications are not FDA-approved
These will help support antioxidant defenses and skin health